Cargando…

Potential value of PRKDC as a therapeutic target and prognostic biomarker in pan-cancer

BACKGROUND: While protein kinase, DNA-activated, catalytic subunit (PRKDC) plays an important role in double-strand break repair to retain genomic stability, there is still no pan-cancer analysis based on large clinical information on the relationship between PRKDC and different tumors. For the firs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiawei, Yang, Feng, Lan, Liugen, Wen, Ning, Li, Haibin, Sun, Xuyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259106/ https://www.ncbi.nlm.nih.gov/pubmed/35801800 http://dx.doi.org/10.1097/MD.0000000000029628

Ejemplares similares

Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma
por: Yang, Xiawei, et al.
Publicado: (2022)

PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy
por: Tan, Kien Thiam, et al.
Publicado: (2020)

Immune landscape in rejection of renal transplantation revealed by high-throughput single-cell RNA sequencing
por: Wen, Ning, et al.
Publicado: (2023)

Role of PRKDC in cancer initiation, progression, and treatment
por: Chen, Yu, et al.
Publicado: (2021)

The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target
por: Gao, Dacheng, et al.
Publicado: (2022)

PRKDC mutations associated with immunodeficiency, granuloma and aire-dependent autoimmunity
por: Belot, Alexandre, et al.
Publicado: (2014)

IL-10 and PRKDC polymorphisms are associated with glioma patient survival
por: Hu, Mingjun, et al.
Publicado: (2016)

The Role of the Exonic lncRNA PRKDC-210 in Transcription Regulation
por: Mo, Junling, et al.
Publicado: (2022)

Susceptibility to adriamycin-induced hepatotoxicity in mice depends on PRKDC polymorphism
por: WATANABE, Masaki, et al.
Publicado: (2023)

Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumors
por: Chen, Yu, et al.
Publicado: (2020)

The value of WNT5A as prognostic and immunological biomarker in pan-cancer
por: Feng, Yingtong, et al.
Publicado: (2022)

Pan-cancer characterization of metabolism-related biomarkers identifies potential therapeutic targets
por: Bi, Guoshu, et al.
Publicado: (2021)

GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer
por: Chen, Guoming, et al.
Publicado: (2022)

Pan-cancer analysis of the immune aspects and prognostic value of NCAPG2
por: Feng, Huidong, et al.
Publicado: (2023)

Primary Founder Mutations in the PRKDC Gene Increase Tumor Mutation Load in Colorectal Cancer
por: Pálinkás, Hajnalka Laura, et al.
Publicado: (2022)

Prognostic value and immunological role of PTPN21 in pan-cancer analysis
por: Yang, YanE, et al.
Publicado: (2023)

Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma
por: Zhang, Lu-yang, et al.
Publicado: (2019)

The potential prognostic values of the ADAMTS-like protein family: an integrative pan-cancer analysis
por: Zhang, Xiaoyue, et al.
Publicado: (2021)

Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
por: Feng, Wenlong, et al.
Publicado: (2020)

Identification of synthetic lethality of PRKDC in MYC-dependent human cancers by pooled shRNA screening
por: Zhou, Zongxiang, et al.
Publicado: (2014)

Impaired Lymphocytes Development and Xenotransplantation of Gastrointestinal Tumor Cells in Prkdc-Null SCID Zebrafish Model()
por: Jung, In Hye, et al.
Publicado: (2016)

Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model
por: Rahman, Shamim H., et al.
Publicado: (2015)

WASF2 Serves as a Potential Biomarker and Therapeutic Target in Ovarian Cancer: A Pan-Cancer Analysis
por: Yang, Xiaofeng, et al.
Publicado: (2022)

Pan-Cancer Analysis Reveals CENPI as a Potential Biomarker and Therapeutic Target in Adrenocortical Carcinoma
por: Wu, Feima, et al.
Publicado: (2023)

The AlkB Family: Potential Prognostic Biomarkers and Therapeutic Targets in Glioblastoma
por: Feng, Songshan, et al.
Publicado: (2022)

COL4A family: potential prognostic biomarkers and therapeutic targets for gastric cancer
por: Zeng, Xi, et al.
Publicado: (2020)

Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases
por: Song, Jialin, et al.
Publicado: (2017)

Non-coding RNA: a potential biomarker and therapeutic target for sepsis
por: Zhang, Tie-Ning, et al.
Publicado: (2017)

Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker
por: Zhou, Bolun, et al.
Publicado: (2021)

High expression of PRKDC promotes breast cancer cell growth via p38 MAPK signaling and is associated with poor survival
por: Zhang, Yan, et al.
Publicado: (2019)

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Zhang, Yinqi, et al.
Publicado: (2021)

Single-cell imaging of normal and malignant cell engraftment into optically clear prkdc-null SCID zebrafish
por: Moore, John C., et al.
Publicado: (2016)

Keratin 80 promotes migration and invasion of colorectal carcinoma by interacting with PRKDC via activating the AKT pathway
por: Li, Changcan, et al.
Publicado: (2018)

Pan-cancer analysis of forkhead box Q1 as a potential prognostic and immunological biomarker
por: Dong, Qiguan, et al.
Publicado: (2022)

KIF11 is a potential prognostic biomarker and therapeutic target for adrenocortical carcinoma
por: Zhou, Yan, et al.
Publicado: (2023)

Potential prognostic and immunotherapeutic value of calponin 1: A pan-cancer analysis
por: Zhou, Hengli, et al.
Publicado: (2023)

Allograft inflammatory factor 1 is a potential diagnostic, immunological, and prognostic biomarker in pan-cancer
por: Liu, Xin, et al.
Publicado: (2023)

Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
por: Xu, Yingting, et al.
Publicado: (2023)

Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker
por: Qiu, Yingqi, et al.
Publicado: (2022)

Pan-cancer analysis reveals that G6PD is a prognostic biomarker and therapeutic target for a variety of cancers
por: Zeng, Tao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9d894tdi1dbm1lbrlk1r495grf